Scientists from the University of Bradford (Bradford, UK) have utilized liquid chromatography?tandem mass spectrometry (LC-MS-MS) to gain further insight into the child sacrifice practices of the Inca people.1 Their findings indicate the use of alcohol and cocaine (COC) as a method of victim sedation.
Scientists from the University of Bradford (Bradford, UK) have utilized liquid chromatography–tandem mass spectrometry (LC–MS–MS) to gain further insight into the child sacrifice practices of the Inca people.1 Their findings indicate the use of alcohol and cocaine (COC) as a method of victim sedation.
In 1999, three bodies were excavated from a sealed chamber at the Andean summit of Volcán Llullaillaco, on the border of Chile and Argentina. The bodies are estimated to have been buried approximately 500 years prior to excavation. Two of the bodies were identified to be around 4—5 years old, and were named the “Llullaillaco Boy” and “Lightening Girl”. The third was identified to be older, at around 13 years of age, and was named “Llullaillaco Maiden”.
The Imperial Inca capachocha rite of human sacrifice was fundamental to establishing social control of the Inca Empire on newly acquired regions; the positioning of the victims on peaks enforced control over an area. According to an earlier study published by the same team,2 over 100 shrines at Inca ritual sites have been recorded between 5200 m and 6700 m on significant peaks throughout the Andean mountain range. The association of specific sites with lightening strikes and volcanic activity is thought to have been key to their selection.
Lead author of the study Andrew Wilson said: “From later Colonial period accounts we have indications that children, often as young as four years old, and ‘acllas’, or chosen women selected around puberty, were donated for sacrifice by their parents and from communities which were under control of the Inca Empire.” He added: “One account suggests that this was an honour and that no sadness could be shown when the children were gifted, but the significance of these transactions as a mechanism of social control must have created a climate of fear amongst such communities.”
Coca leaves were found at the site, along with other “offerings”. Cut scalp hair samples, collected in 2003, were defrosted and prepared for LC–MS–MS. Three markers were tested for in the hair samples — COC, the major alkaloid in coca leaves; bezoylecgonine (BZE), the major metabolite of COC; and coca ethylene (COCE), formed in the presence of alcohol. Samples from self-reporting COC users in rehabilitation were used as positive controls. A volume of 5 µL of each sample extract was injected onto a reversed-phase column and analysed by triple quadrupole mass spectrometry using electrospray ionization in positive ion mode.
Wilson told The Column: “Our approach enabled us to use the minimum of hair to safeguard their exceptionally well-preserved remains, with each segment along these hairs representing roughly six weeks in the lives of these children.” The hair braid of the “Maiden” was two metres long, providing what the authors approximated as a two‑year time-line before her death. The analysis indicated a change in her diet, and therefore her social status, a year before her death.
Wilson said: “We think it’s likely the Maiden was selected for sacrifice 12 months before her death, after which her treatment changed, corresponding to the sharp increase in coca consumption. She was then probably involved in a series of rituals, involving consumption of coca and alcohol, in the build up to her sacrifice, which kept consumption at a steady level.” He added: “Both substances were controlled, were considered elite products, and held ritual significance for the Inca.”
The paper’s co-author and National Geographic Society Explorer-in-Residence, Johan Reinhard, said: “With their extraordinary preservation, these children have yielded more information about the past than we could have hoped, thanks to advances in technology. I believe they have much more to tell us and it’s difficult to imagine anything, however rare, that can compare with the uniqueness and complexity of information provided by a frozen mummy.” — B.D.
References
1. A.S. Wilson et al., PNAS Early Edition, DOI: 10.1073/pnas.1305117110 (2013).
2. A.S. Wilson et al., PNAS104(42), 16456–16461 (2007).
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.